Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yabin Cheng

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Carcinogenesis|September 26, 2013
JWA inhibits melanoma angiogenesis by suppressing ILK signaling and is an independent prognostic biomarker for melanomaJing Lu, Yun Tang, Maham Farshidpour, et al.
Molecular Cell|June 27, 2020
eIF3 Associates with 80S Ribosomes to Promote Translation Elongation, Mitochondrial Homeostasis, and Muscle HealthYingying Lin, Fajin Li, Linlu Huang, et al.
Oncotarget|July 6, 2015
Therapeutic efficacy of combined BRAF and MEK inhibition in metastatic melanoma: a comprehensive network meta-analysis of randomized controlled trialsRuiqin Mai, Songxia Zhou, Weixiang Zhong, et al.
The EMBO Journal|May 8, 2023
eIF3 mRNA selectivity profiling reveals eIF3k as a cancer-relevant regulator of ribosome contentHaoran Duan, Siqiong Zhang, Yoram Zarai, et al.
Cell Chemical Biology|December 1, 2021
Metabolic targeting of cancer by a ubiquinone uncompetitive inhibitor of mitochondrial complex IShashi Jain, Cheng Hu, Jerome Kluza, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Carcinogenesis|September 26, 2013
JWA inhibits melanoma angiogenesis by suppressing ILK signaling and is an independent prognostic biomarker for melanomaJing Lu, Yun Tang, Maham Farshidpour, et al.
Molecular Cell|June 27, 2020
eIF3 Associates with 80S Ribosomes to Promote Translation Elongation, Mitochondrial Homeostasis, and Muscle HealthYingying Lin, Fajin Li, Linlu Huang, et al.
Oncotarget|July 6, 2015
Therapeutic efficacy of combined BRAF and MEK inhibition in metastatic melanoma: a comprehensive network meta-analysis of randomized controlled trialsRuiqin Mai, Songxia Zhou, Weixiang Zhong, et al.
The EMBO Journal|May 8, 2023
eIF3 mRNA selectivity profiling reveals eIF3k as a cancer-relevant regulator of ribosome contentHaoran Duan, Siqiong Zhang, Yoram Zarai, et al.
Cell Chemical Biology|December 1, 2021
Metabolic targeting of cancer by a ubiquinone uncompetitive inhibitor of mitochondrial complex IShashi Jain, Cheng Hu, Jerome Kluza, et al.
Pageof 4